Finance

Lists
NAMSW:NASDAQ
NewAmsterdam Pharma Company N.V.
$9.00
0.00%
(0.00) 1D
Oct 16, 3:12:37 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAMSW...
Mkt. cap
2.43B
Avg. vol.
485.00
Volume
2.00
52-wk high
$30.00
52-wk low
$8.82
Beta
6.47
No. of employees
100
Mkt. cap
2.43B
Avg. vol.
485.00
Volume
2.00
52-wk high
$30.00
52-wk low
$8.82
Beta
6.47
No. of employees
100
News stories
From web sources and news partners
About NewAmsterdam Pharma Company N.V.
CEO-
Employees100
Founded2019
Headquarters-
SectorBiotechnology
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
348.00K
32.00K
3.04M
3.70M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
30.97M
38.59M
38.01M
41.67M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.52M
27.42M
23.45M
26.89M
Operating expense
55.49M
66.01M
61.46M
68.56M
Total operating expenses
55.49M
66.01M
61.46M
68.56M
Operating income
-55.14M
-65.98M
-58.42M
-64.86M
Other non operating income
-23.79M
-15.34M
5.94M
-4.56M
EBT including unusual items
-72.00M
-74.92M
-48.44M
-64.14M
EBT excluding unusual items
-72.00M
-74.92M
-48.44M
-64.14M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-72.00M
-74.92M
-48.44M
-64.14M
Net profit margin
-20,691.09%
-234,134.38%
-1,593.45%
-1,732.91%
Earnings per share
-
-
-
-
Interest and investment income
6.71M
6.47M
5.65M
5.81M
Interest expense
-
-
-
-
Net interest expenses
6.71M
6.47M
5.65M
5.81M
Depreciation and amortization charges
-
-
-
-
EBITDA
-55.08M
-65.92M
-58.36M
-64.80M
Gain or loss from assets sale
1.00K
11.00K
12.00K
6.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps